Venz S et al. |
Contribution of color and power Doppler sonography to the differential diagnosis of acute and chronic rejection, and tacrolimus nephrotoxicity in renal allografts. |
1999 |
Transpl. Int. |
pmid:10363595
|
Onsager DR et al. |
Efficacy of tacrolimus in the treatment of refractory rejection in heart and lung transplant recipients. |
1999 |
J. Heart Lung Transplant. |
pmid:10363689
|
Ito F et al. |
FK506 and cyclosporin A inhibit stem cell factor-dependent cell proliferation/survival, while inducing upregulation of c-kit expression in cells of the mast cell line MC/9. |
1999 |
Arch. Dermatol. Res. |
pmid:10367710
|
Przepiorka D et al. |
Relationship of tacrolimus whole blood levels to efficacy and safety outcomes after unrelated donor marrow transplantation. |
1999 |
Biol. Blood Marrow Transplant. |
pmid:10371361
|
Matzinger P |
Graft tolerance: a duel of two signals. |
1999 |
Nat. Med. |
pmid:10371494
|
Kirk AD et al. |
Treatment with humanized monoclonal antibody against CD154 prevents acute renal allograft rejection in nonhuman primates. |
1999 |
Nat. Med. |
pmid:10371508
|
Lieberman DN and Mody I |
Properties of single NMDA receptor channels in human dentate gyrus granule cells. |
1999 |
J. Physiol. (Lond.) |
pmid:10373689
|
Cox KL et al. |
Paediatric liver transplantation: indications, timing and medical complications. |
1999 |
J. Gastroenterol. Hepatol. |
pmid:10382641
|
Higgins RM et al. |
Conversion between cyclosporin and tacrolimus--30-fold dose prediction. |
1999 |
Nephrol. Dial. Transplant. |
pmid:10383044
|
Henry ML |
Cyclosporine and tacrolimus (FK506): a comparison of efficacy and safety profiles. |
1999 |
Clin Transplant |
pmid:10383101
|
Koski GK et al. |
Calcium mobilization in human myeloid cells results in acquisition of individual dendritic cell-like characteristics through discrete signaling pathways. |
1999 |
J. Immunol. |
pmid:10384103
|
Leung W et al. |
Long-term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders complicating liver transplant. |
1999 |
Transplantation |
pmid:10385092
|
Squadrito F et al. |
Tacrolimus suppresses tumour necrosis factor-alpha and protects against splanchnic artery occlusion shock. |
1999 |
Br. J. Pharmacol. |
pmid:10385251
|
Gerhardt U et al. |
Blood pressure control in kidney transplant recipients: influence of immunosuppression. |
1999 |
J Auton Pharmacol |
pmid:10385269
|
Liang H et al. |
Regulation of angiotensin II-induced phosphorylation of STAT3 in vascular smooth muscle cells. |
1999 |
J. Biol. Chem. |
pmid:10391929
|
Hasselder AS |
The nursing management of a patient receiving Prograf as a primary immunosuppressive agent. |
1998 Apr-Jun |
EDTNA ERCA J |
pmid:10392057
|
Horowitz MM et al. |
Tacrolimus vs. cyclosporine immunosuppression: results in advanced-stage disease compared with historical controls treated exclusively with cyclosporine. |
1999 |
Biol. Blood Marrow Transplant. |
pmid:10392964
|
Kochi S et al. |
Effect of cyclosporin A or tacrolimus on the function of blood-brain barrier cells. |
1999 |
Eur. J. Pharmacol. |
pmid:10395024
|
Magee CC et al. |
Immunosuppressive agents in organ transplantation. |
1999 |
Hosp Med |
pmid:10396414
|
Gold BG et al. |
Efficacy of delayed or discontinuous FK506 administrations on nerve regeneration in the rat sciatic nerve crush model: lack of evidence for a conditioning lesion-like effect. |
1999 |
Neurosci. Lett. |
pmid:10400242
|